#rd
Cyient Semiconductors raises $30 m at $500 m valuation
Cyient Semiconductors raises $30 million from Edelweiss to enhance R&D and expand its semiconductor capabilities globally.
Cyient Semiconductors raises $30 m at $500 m valuation
Cyient Semiconductors raises $30 million from Edelweiss to enhance R&D and expand its semiconductor capabilities globally.
India should increase investment in R&D to 2 per cent of GDP: Niti Aayog
Niti Aayog has urged India to boost research and development investment to two percent of GDP within five years. The report suggests restoring a five percent GST slab for R&D procurement. It also calls for fiscal incentives to encourage private sector R&D spe…
Cipla bets on fast-growing biosimilars market, to steadily add products: CEO
Cipla is developing a biosimilars pipeline, with plans to add 1-2 products yearly for the next five years. The drugmaker is investing in R&D, especially for developed markets, to build out a strong pipeline across respiratory, peptides as well as complex …
Your Power Tools Got Worse On Purpose | Who Really Owns DeWalt, Craftsman, and Milwaukee?
How TTI and Stanley Black & Decker took the same playbook in opposite directions. One invested $206M in R&D and grew to 4,000 workers. The other is $6 billion in debt and closing its hometown factory.
India’s policy push to boost aerospace manufacturing: Thales
Thales emphasizes India's aerospace manufacturing growth driven by policy support, R&D, and rising defense expenditures, enhancing local partnerships.
Coronavirus Vaccine Market Research Report 2026 - Global Analysis, Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031
The Global Coronavirus Vaccine Market sees growth opportunities driven by the need for updated vaccines against new viral variants, ongoing R&D for pan-coronavirus vaccines, non-injectable formulations, and strong government support. Challenges include global…
Taiwan's MediaTek expands India footprint with new Noida R&D centre
Taiwanese semiconductor giant MediaTek has established its second Indian R&D hub in Noida, leasing 1,04,000 sq ft at BPTP's Capital City. This move, valued at approximately Rs. 144 crore, underscores Noida's growing appeal for global tech firms seeking qualit…
Biosimulation Market to Grow at 16%+ CAGR Reaching USD 11.3 Billion by 2031, Driven by Increasing Adoption in Drug Development and Regulatory Applications: Mordor Intelligence
The biosimulation market is driven by the rising complexity of drug development, increasing demand for cost-efficient R&D processes, and growing adoption of modeling and simulation tools. North America leads the market, while Asia-Pacific is emerging as a hig…
Sun Pharma’s deal to buy Merck-spinoff Organon ticks the right box on acquisition cost if not R&D
Sun Pharma’s acquisition of US-based Organon looks like a financial bargain for the global scale and market access it offers. But the Indian drugmaker may need to look elsewhere for an R&D boost that could put it at the cutting edge of healthcare.